8 hours ago
1
JHVEPhoto/iStock Editorial via Getty Images
Despite posting a double beat with its Q4 FY25 financials, shares of Medtronic (NYSE:MDT) slipped in the premarket trading on Wednesday after the Ireland-based MedTech set its fiscal 2026 guidance below expectations.
The company set its outlook for FY26 revenue
English (US) ·